Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protalix BioTherapeutics (PLX) Current Deferred Revenue (2016 - 2025)

Protalix BioTherapeutics has reported Current Deferred Revenue over the past 16 years, most recently at $2.0 million for Q1 2025.

  • Quarterly results put Current Deferred Revenue at $2.0 million for Q1 2025, down 81.88% from a year ago — trailing twelve months through Mar 2025 was $2.0 million (down 81.88% YoY), and the annual figure for FY2022 was $13.2 million, up 54.13%.
  • Current Deferred Revenue for Q1 2025 was $2.0 million at Protalix BioTherapeutics, down from $12.7 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for PLX hit a ceiling of $18.1 million in Q2 2021 and a floor of $2.0 million in Q1 2025.
  • Median Current Deferred Revenue over the past 5 years was $11.8 million (2022), compared with a mean of $11.0 million.
  • Biggest five-year swings in Current Deferred Revenue: crashed 86.54% in 2021 and later soared 360.98% in 2022.
  • Protalix BioTherapeutics' Current Deferred Revenue stood at $8.5 million in 2021, then skyrocketed by 54.13% to $13.2 million in 2022, then dropped by 10.53% to $11.8 million in 2023, then increased by 7.68% to $12.7 million in 2024, then plummeted by 84.25% to $2.0 million in 2025.
  • The last three reported values for Current Deferred Revenue were $2.0 million (Q1 2025), $12.7 million (Q2 2024), and $11.0 million (Q1 2024) per Business Quant data.